Help us understand attention Learn more

Eye Movement Control in Adults

View as

Summary

Many researchers are finding that by the time a patient seeks treatment for symptoms of Alzheimer's disease, it's often too late for the available drugs to have an effect. Dr. Adam Boxer's lab is studying very precise eye tracking methods to gauge mental fitness and identify cognitive decline decades before the first symptoms appear.

Study director: Adam Boxer, MD, PhD
Sponsor: National Institutes of Health (NIH)
Recruiting?: Yes
Official study title: Eye movement control in normal adults and in adults with neurologic disease
Conditions studied: Frontotemporal dementia (FTD), semantic dementia (SD), progressive non-fluent aphasia (PNFA), Alzheimer's disease (AD), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and healthy adults
Purpose: To learn about the mechanisms of eye movement control and visual perception, as well as how these functions may change with different neurologic diseases.